width=We have just awarded funding to Margot Mayer-Proschel, PhD at the University of Rochester to characterize a new mouse model that her lab has developed for A-T. Previous A-T mouse models have been useful for studying the biochemical, cancer, and immunological problems associated with A-T but haven’t had the brain degeneration and loss of muscle control seen in humans with the disease. And so, for the first time in history, Dr. Mayer-Proschel’s mice may allow researchers to overcome a huge barrier that has hampered A-T researchers from testing new therapies for the devastating neurological problems of A-T.

Contact Us

Related News

Jun 23 @ 2:21 am

Art of Nursing Award

A-T Clinic Nurse, Jenny Wright, RN is the recipient of the 2024 Art of Nursing award!

more
Jun 23 @ 2:21 am

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

more
Jun 23 @ 2:21 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

more
Jun 23 @ 2:21 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.

more